Log in

NASDAQ:BBH - VanEck Vectors Biotech ETF Stock Price, Forecast & News

$144.75
+0.41 (+0.28 %)
(As of 02/23/2020 03:19 PM ET)
Today's Range
$143.22
Now: $144.75
$145.00
50-Day Range
$132.39
MA: $139.56
$144.75
52-Week Range
$113.89
Now: $144.75
$145.00
Volume15,653 shs
Average Volume14,265 shs
Market Capitalization$369.11 million
P/E RatioN/A
Dividend Yield0.33%
Beta1.39

Basic Details

Issuer Van Eck
Fund NameVanEck Vectors Biotech ETF
Tax ClassificationRegulated Investment Company
SymbolNASDAQ:BBH
Inception Date12/20/2011
Fund ManagerHao-Hung Peter Liao, Guo Hua Jason Jin
WebN/A
PhoneN/A

Fund Focus

Asset ClassEquity
BenchmarkMarket Vectors US Listed Biotech 25 Index
CategorySector
FocusHealth Care
Development LevelDeveloped Markets
RegionGlobal

Fund Statistics

Assets Under Management$1.92 billion
Average Daily Volume$14,048.50
Discount/Premium-1.27%

ETF Expenses

Management Fee0.35%
Other Expenses0.04%
Total Expenses0.39%
Fee Waiver-0.04%
Net Expenses0.35%

Administrator, Advisor and Custodian

AdministratorVan Eck Associates Corporation
AdvisorVan Eck Associates Corporation
CustodianThe Bank of New York Mellon Corporation
DistributorVan Eck Securities Corporation
Transfer AgentThe Bank of New York Mellon Corporation
Trustee
Lead Market MakerVirtu Financial

Receive BBH News and Ratings via Email

Sign-up to receive the latest news and ratings for BBH and its competitors with MarketBeat's FREE daily newsletter.


Geographic Exposure of VanEck Vectors Biotech ETF (NASDAQ:BBH)
Currency Exposure of VanEck Vectors Biotech ETF (NASDAQ:BBH)
Sector Exposure of VanEck Vectors Biotech ETF (NASDAQ:BBH)
Industry Exposure of VanEck Vectors Biotech ETF (NASDAQ:BBH)

VanEck Vectors Biotech ETF (NASDAQ:BBH) Frequently Asked Questions

What is VanEck Vectors Biotech ETF's stock symbol?

VanEck Vectors Biotech ETF trades on the NASDAQ under the ticker symbol "BBH."

Has VanEck Vectors Biotech ETF been receiving favorable news coverage?

News coverage about BBH stock has been trending negative recently, according to InfoTrie Sentiment. The research firm identifies positive and negative press coverage by reviewing more than six thousand news and blog sources in real time. The firm ranks coverage of companies on a scale of -5 to 5, with scores closest to five being the most favorable. VanEck Vectors Biotech ETF earned a media sentiment score of -2.4 on InfoTrie's scale. They also gave headlines about the company a news buzz of 0.0 out of 10, meaning that recent press coverage is extremely unlikely to have an impact on the company's share price in the near future. View News Stories for VanEck Vectors Biotech ETF.

Who are some of VanEck Vectors Biotech ETF's key competitors?

What other stocks do shareholders of VanEck Vectors Biotech ETF own?

Based on aggregate information from My MarketBeat watchlists, some companies that other VanEck Vectors Biotech ETF investors own include Arlo Technologies (ARLO), International Game Technology (IGT), SPDR S&P 500 ETF Trust (SPY), Alliance MMA (AMMA), Ashford (AINC), Allied Healthcare Products (AHPI), Adobe (ADBE), B&M European Value Retail (BME), Anglo American (AAL) and Deutsche Bank (DBK).

Who are VanEck Vectors Biotech ETF's major shareholders?

VanEck Vectors Biotech ETF's stock is owned by a variety of of institutional and retail investors. Top institutional shareholders include UBS Group AG (1.81%), Murphy Capital Management Inc. (1.43%), Bank of America Corp DE (1.26%), Mogy Joel R Investment Counsel Inc. (0.93%), Jane Street Group LLC (0.79%) and Raymond James & Associates (0.58%).

Which institutional investors are selling VanEck Vectors Biotech ETF stock?

BBH stock was sold by a variety of institutional investors in the last quarter, including UBS Group AG, Institute for Wealth Management LLC., Tower Research Capital LLC TRC , Bank of America Corp DE, Boston Research & Management Inc., Murphy Capital Management Inc., Aspiriant LLC and Advisor Group Inc..

Which institutional investors are buying VanEck Vectors Biotech ETF stock?

BBH stock was acquired by a variety of institutional investors in the last quarter, including Jane Street Group LLC, Raymond James Financial Services Advisors Inc., Ironsides Asset Advisors LLC, Raymond James & Associates, Tufton Capital Management, Bailard Inc., Cypress Capital Group and Howard Wealth Management LLC.

How do I buy shares of VanEck Vectors Biotech ETF?

Shares of BBH can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

What is VanEck Vectors Biotech ETF's stock price today?

One share of BBH stock can currently be purchased for approximately $144.75.

How big of a company is VanEck Vectors Biotech ETF?

VanEck Vectors Biotech ETF has a market capitalization of $369.11 million. View Additional Information About VanEck Vectors Biotech ETF.


MarketBeat Community Rating for VanEck Vectors Biotech ETF (NASDAQ BBH)

Community Ranking:  2.5 out of 5 (star star half star)
Outperform Votes:  37 (Vote Outperform)
Underperform Votes:  37 (Vote Underperform)
Total Votes:  74
MarketBeat's community ratings are surveys of what our community members think about VanEck Vectors Biotech ETF and other stocks. Vote "Outperform" if you believe BBH will outperform the S&P 500 over the long term. Vote "Underperform" if you believe BBH will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 2/23/2020 by MarketBeat.com Staff

Featured Article: FinTech

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel